Geode Capital Management’s Response Genetics RGDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-99,700
Closed -$32K – 4198
2015
Q2
$32K Hold
99,700
– – ﹤0.01% 3908
2015
Q1
$45K Hold
99,700
– – ﹤0.01% 3863
2014
Q4
$31K Hold
99,700
– – ﹤0.01% 3927
2014
Q3
$68K Hold
99,700
– – ﹤0.01% 3809
2014
Q2
$91K Buy
99,700
+84,697
+565% +$88.6K ﹤0.01% 3717
2014
Q1
$17K Buy
+15,003
New +$20.9K ﹤0.01% 3805

Geode Capital Management's RGDX Position: Q3 2015 in Review

Geode Capital Management sold out of Response Genetics (RGDX) in Q3 2015, closing a stake of 99,700 shares — an estimated $32K sold.

Geode Capital Management first reported a position in RGDX in Q1 2014 and held it in 6 quarters. The position peaked at $91K in Q2 2014. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

  • Geode Capital Management reported no remaining Response Genetics position as of Q3 2015 after selling out during the quarter.
  • Geode Capital Management sold 99,700 Response Genetics shares in Q3 2015, an estimated $32K.
  • Geode Capital Management first reported a position in Response Genetics in Q1 2014 and held it in 6 quarters.
  • Geode Capital Management's Response Genetics position peaked at $91K in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Response Genetics as of Q3 2015.

Based on Geode Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.